2028年亚太地区药物输送市场预测 - COVID-19影响和区域分析 - 按给药途径(注射药物输送、口服药物输送、经粘膜药物输送、局部药物输送、植入式药物输送和眼部药物输送)、分销渠道(医院药房、零售药房和在线药房)和最终用户(医院和诊所、家庭护理机构和其他最终用户)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 248    |    Report Code: BMIRE00028750    |    Category: Life Sciences

Asia Pacific Drug Delivery Market

亚太地区给药市场预计将从2023年的4429.737亿美元增长到2028年的66784274万美元。预计从2023年起复合年增长率为8.6%到 2028 年。

对无创给药系统不断增长的需求推动亚太给药市场

< /h3>

患者依从性低是医生和医疗设备制造商的一个值得注意的问题。因此,制造商专注于开发用户友好且直观的药物输送系统,为患者提供高舒适度。医生、护理人员和患者寻求更多以患者为中心的解决方案,评估输送系统和包装选项,以鼓励患者按指示服用药物。准确测量的剂量和易于使用且标签清晰的包装对于满足自给自足的需求至关重要。包装还必须是儿童安全的,并且应禁止伪造。

创新形式的单位剂量包装越来越多地用于提高患者对处方药物治疗的依从性。单位剂量包装或容器被精确地填充以容纳用于单剂量的数量的药物。这些功能减少了用药错误,因为药物的身份很快得到确认,并且包装可确保患者服用正确剂量的药物。药品制造商现在专注于药物输送系统,该系统为患者在家里以外的地方服用药物提供易用性、便携性和便利性。 Unither Pharmaceuticals – 专门从事无菌、单剂量药物的开发和合同制造 – 提供一系列方便且易于使用的剂型和给药系统。各种形式包括棒状包装、采用吹灌封 (BFS) 技术的单剂量小瓶和泡腾片。使用 BFS 和棒状包装技术的药物输送系统有助于确保准确的剂量,并为患者提供更安全、便携、更方便的方式来坚持治疗方案。这些单剂量系统有助于区分不同的药品并延长产品生命周期,从而使制造商受益。

诺和诺德开发了一款 FlexTouch 胰岛素笔,注射所需的力更小,剂量结束时的咔嗒声可确保准确的剂量输送,细针可减轻注射时的疼痛。此外,鼻喷雾剂会流到喉咙,这是鼻喷雾剂的主要问题之一;因此,OptiNose 开发了一种创新的吸入器,专门将药物输送到鼻腔中。公司还强调,让患者能够使用他们已经熟悉的舒适设备来治疗新的适应症,从而提高患者的便利性。葛兰素史克 (GlaxoSmithKline) 提供 Breo Ellipta 吸入器,用于治疗慢性阻塞性肺病 (COPD) 和哮喘患者,此外,其最初的适应症是每天一次的呼吸吸入器。一些公司还在开发能够传输更粘稠的药物产品、更大的分子和更高剂量浓度的设备,而通过手动输送方法注射这些药物通常是困难和痛苦的。此类创新产品有助于提高患者的依从性并减少用药错误的机会。因此,对患者依从性和满意度的日益关注为亚太地区给药系统市场的增长提供了重要机遇。

亚太地区给药系统市场概览< /strong>

亚太地区是全球药物输送设备增长最快的市场,其中中国、印度和日本是三个主要贡献者。亚太地区药物输送市场的推动因素是人们对慢性疾病的认识不断提高,以及越来越多的制药和生物技术公司专注于亚太地区国家的地理扩张和其他战略。此外,研究中心和政府资助的增加推动了市场的增长。此外,泰国、新加坡和马来西亚对治疗的需求不断增长以及医疗旅游业的增长正在推动该地区的市场。

亚太地区药物输送市场收入到 2028 年的预测(百万美元)

亚太药物输送市场细分

亚太地区药物输送市场分为给药途径、分销渠道、最终用户和国家。

根据给药途径,亚太地区给药市场分为注射给药、口服给药、经粘膜给药、局部给药、植入式给药和眼部给药。 2023年注射给药市场在亚太给药市场中占有较大份额。

根据分销渠道,亚太给药市场分为医院药房、零售药店和网上药店。 2023年,医院药房细分市场在亚太地区给药市场中占据最大份额。

根据最终用户,亚太地区给药市场分为医院和诊所、家庭护理机构和其他最终用户。 2023年,医院和诊所在亚太地区给药市场中占据最大份额。

按国家/地区划分,亚太地区给药市场分为日本、中国、印度、韩国、澳大利亚和亚太其他地区。 2023 年,日本在亚太给药市场中占据主导地位。

Bausch Health Companies Inc、Baxter International Inc、Becton Dickinson and Co、Boehringer Ingelheim International GmbH、波士顿科学公司、Gerresheimer AG、葛兰素史克公司、强生公司强生、诺华、诺和诺德和辉瑞是亚太药物输送市场的领先公司。   



Asia Pacific Drug Delivery Strategic Insights

Strategic insights for Asia Pacific Drug Delivery involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-drug-delivery-market-strategic-framework.webp
Get more information on this report

Asia Pacific Drug Delivery Report Scope

Report Attribute Details
Market size in 2023 US$ 4,42,973.70 Million
Market Size by 2028 US$ 6,67,842.74 Million
Global CAGR (2023 - 2028) 8.6%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 给药途径
  • 注射给药
  • 口服给药
  • 透粘膜给药
  • 局部给药
  • 植入给药
  • 眼部给药
By 分销渠道
  • 医院药房
  • 零售药房
  • 网上药房
By 最终用户
  • 医院和诊所
  • 家庭护理机构
  • 其他最终用户
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Bausch Health Companies Inc
  • Baxter International Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Novo Nordisk AS
  • Get more information on this report

    Asia Pacific Drug Delivery Regional Insights

    The regional scope of Asia Pacific Drug Delivery refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-drug-delivery-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Drug Delivery Market

    1. Bausch Health Companies Inc
    2. Baxter International Inc
    3. Becton Dickinson and Co
    4. Boehringer Ingelheim International GmbH
    5. Boston Scientific Corp
    6. Gerresheimer AG
    7. GlaxoSmithKline Plc
    8. Johnson & Johnson
    9. Novartis AG
    10. Novo Nordisk AS
    11. Pfizer Inc
    Frequently Asked Questions
    How big is the Asia Pacific Drug Delivery Market?

    The Asia Pacific Drug Delivery Market is valued at US$ 4,42,973.70 Million in 2023, it is projected to reach US$ 6,67,842.74 Million by 2028.

    What is the CAGR for Asia Pacific Drug Delivery Market by (2023 - 2028)?

    As per our report Asia Pacific Drug Delivery Market, the market size is valued at US$ 4,42,973.70 Million in 2023, projecting it to reach US$ 6,67,842.74 Million by 2028. This translates to a CAGR of approximately 8.6% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Drug Delivery Market report typically cover these key segments-

  • 给药途径 (注射给药, 口服给药, 透粘膜给药, 局部给药, 植入给药, 眼部给药)
  • 分销渠道 (医院药房, 零售药房, 网上药房)
  • 最终用户 (医院和诊所, 家庭护理机构, 其他最终用户)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Drug Delivery Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Drug Delivery Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Asia Pacific Drug Delivery Market?

    The Asia Pacific Drug Delivery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bausch Health Companies Inc
  • Baxter International Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corp
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc
  • Who should buy this report?

    The Asia Pacific Drug Delivery Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Drug Delivery Market value chain can benefit from the information contained in a comprehensive market report.